15.05.2017 | Fundraising
ZAG-S&W represented BiomX in a Dual Listing on the Tel-Aviv Stock Exchange.
Adv. Shy Baranov from the International Department and Adv. Reut Alfiah from the Capital Markets Department advised the biomed company BiomX in a Dual Listing on the Tel-Aviv Stock Exchange.
BiomX, formerly MBCure, was founded in the Futurx Technology Incubator. It develops innovative drugs to treat a variety of diseases caused by microbial imbalance.